Execus (EXEC) H1 2026 earnings summary

Executive summary

• H1 2026 sales rose 18.3% YoY to €4.701m; recurring and AI-based/powered revenue shares increased to 67.5% and 58.4%, respectively.

• EBITDA increased 7.0% to €517k, while EBIT turned negative at €141k and net loss widened to €242k; adjusted EBITDA was €635k.

• Second-half priorities include commercializing AI agents and GLOPS, expanding retail media, and realizing cost-efficiency benefits; outlook described as positive.

Financial highlights

• Sales revenue €4.701m, up 18.3% YoY; value of production €4.765m, up 8.5%.

• Net loss €242k vs €48k in H1 2025; €210k attributable to owners and €32k to non-controlling interests.

• Operating cash flow was negative €1.123m; investing cash outflow €427k and financing inflow €837k; cash ended at €841k.

• Sales growth included €598k organic growth across existing entities and €130k from Vanilla, which was not consolidated in H1 2025.

Outlook and guidance

• H2 2026 outlook is positive, supported by scalable recurring-revenue models, AI-enabled offerings, integrated services, and ongoing commercial development.

• AI agents were slated for commercial launch in October; GLOPS and GLOPS business unit GLOPS? are entering operational and go-to-market stages in H2.

• Cost-efficiency initiatives, focused particularly on recently acquired businesses, are expected to support margins in coming months; significant near-term investment will continue.